Biphasic control of the B cell transcriptome by mTORC1 and GSK3
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Jens Kalchschmidt und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jens.kal…. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, B-Lymphocytes, Glycogen Synthase Kinase 3, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
Abstract (Originalsprache)
A central question in immune regulation is how cells coordinate transcriptional responses to environmental cues. It remains unclear whether transcriptional regulation is controlled by isolated mechanism or integrated regulatory programs. Here, we develop a high-sensitivity, genome-wide CRISPR-Cas9 screening platform with 47 transcriptional reporters in human B cell lymphoma, identifying 4,440 regulators and 17,638 regulatory interactions. To enable the exploration of these networks, we establish B-LEARN, an interactive portal for data visualization and discovery. Our results reveal a large number of shared regulators across our 47 screens that act as context-dependent activators or repressors. Globally, we uncover a biphasic regulatory architecture in which mTORC1 and GSK3 exert opposing control over the B cell transcriptome. Notably, mTOR inhibition broadly activates key B cell genes, an effect antagonized by GSK3. Thus, B cell transcription is governed by an integrated, pathway-driven circuit, offering new targets to modulate gene expression in lymphoma and autoimmune disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jens.kalchschmidt@nih.gov.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
- National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: john.oshea@nih.gov.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: rcasellas@mdanderson.org.
Förderung
- Intramural NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- National Cancer Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Kalchschmidt, J., Kanno, T., Park, S., Dubois, W. D., Zhao, Y., Trzaskoma, P., Thomas, C. J., Staudt, L. M., O'Shea, J. J., Jung, S., & Casellas, R. (2025). Biphasic control of the B cell transcriptome by mTORC1 and GSK3. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116361
Vancouver
Kalchschmidt J, Kanno T, Park S, Dubois WD, Zhao Y, Trzaskoma P, et al. Biphasic control of the B cell transcriptome by mTORC1 and GSK3. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116361
BibTeX
@article{Kalchschmidt2025,
author = {Kalchschmidt, Jens and Kanno, Tomoya and Park, Solji and Dubois, Wendy D and Zhao, Yongbing and Trzaskoma, Pawel and Thomas, Craig J and Staudt, Louis M and O'Shea, John J and Jung, Seolkyoung and Casellas, Rafael},
title = {Biphasic control of the B cell transcriptome by mTORC1 and GSK3},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116361}
}
EUVIMED